Subject: EASL Recommendations on Treatment of Hepatitis C 2020
From: EASL Office <[email-masked]>
To: [email-masked]
Date: Sat, 19 Sep 2020 06:10:52 +0000

Now available on the EASL website

19 September 2020

Read online

In the spotlight

We are glad to inform you that the final update of the EASL Recommendations on Treatment of Hepatitis C is now available on the EASL website.

Clinical care for patients with HCV-related liver disease has advanced considerably thanks to an enhanced understanding of the pathophysiology of the disease, as well as developments in diagnostic procedures and improvements in therapy and prevention. These therapies make it possible to eliminate hepatitis C as a major public health threat, as per the World Health Organization target, although the timeline and feasibility vary from region to region.

This final update of the EASL Recommendations on Treatment of Hepatitis C series is intended to assist physicians and other healthcare providers, as well as patients and other interested individuals, in the clinical decision-making process, by describing the optimal management of patients with acute and chronic HCV infections in 2020 and onwards.

The EASL Recommendations on Treatment of Hepatitis C are now available online and will be simultaneously published in the Journal of Hepatology.

This version supersedes the earlier version published earlier in the week.

Download it now!

Download the EASL app

Access event info, EASL Campus and stay informed with the latest messages and news.

For the latest news on COVID-19 and liver disease, follow us on Twitter

@EASLnews and @EASLedu

Share with a friend or colleague

EASL’s mission is supported by an unrestricted education grant from Abbvie and Bristol-Myers Squibb.

EASL, The Home of Hepatology

7 rue Daubin, 1203 Geneva, Switzerland

+41 22 807 03 60

www.easl.eu

[email-masked]

Update your preferences or unsubscribe